Cumulative incidence, risk factors and prognostic impact of venous thromboembolism in Japanese patients with advanced gastric cancer

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Japanese Journal of Clinical Oncology

• Publication date

  2017-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/jjco/hyx107PMID 28981740
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer.

  2015cited by this paper
• Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014.

  2015cited by this paper
• Obesity measures and risk of venous thromboembolism and myocardial infarction

  2014cited by this paper
• Role of Obesity in the Etiology of Deep Vein Thrombosis and Pulmonary Embolism: Current Epidemiological Insights

  2013cited by this paper
• Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis

  2012cited by this paper
• Venous thromboembolism (VTE) in patients with advanced gastric cancer: an Asian experience.

  2012cited by this paper
• Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study.

  2011cited by this paper
• The influence of abdominal pressure on lower extremity venous pressure and hemodynamics: a human in-vivo model simulating the effect of abdominal obesity.

  2011cited by this paper
• Inflammatory mechanisms in obesity.

  2011cited by this paper
• Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

  2010cited by this paper
• Risk Factors for Venous Thromboembolism: Results From the Copenhagen City Heart Study

  2010cited by this paper
• The incidence, risk factors and prognostic implications of venous thromboembolism in patients with gastric cancer

  2010cited by this paper
• Impact of obesity on venous hemodynamics of the lower limbs.

  2010cited by this paper
• Effects of race and ethnicity on the incidence of venous thromboembolism.

  2009cited by this paper
• Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group.

  2009cited by this paper
• Development and validation of a predictive model for chemotherapy-associated thrombosis.

  2008cited by this paper
• S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

  2008cited by this paper
• Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients

  2008cited by this paper
• Trousseau's syndrome: multiple definitions and multiple mechanisms.

  2007cited by this paper
• The impact on survival of thromboembolic phenomena occurring before and during protocol chemotherapy in patients with advanced gastroesophageal adenocarcinoma

  2007cited by this paper
• Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy

  2007cited by this paper
• Risk factors for venous thromboembolic events in cancer patients.

  2006cited by this paper
• Chemotherapy-induced thrombosis.

  2006cited by this paper
• Incidence of venous thromboembolism and its effect on survival among patients with common cancers.

  2006cited by this paper
• Bidirectional Relation Between Inflammation and Coagulation

  2004cited by this paper
• Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas.

  2003cited by this paper
• Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

  2002cited by this paper
• Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis.

  2000cited by this paper
• Prognosis of cancers associated with venous thromboembolism.

  2000cited by this paper
• Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening.

  1997cited by this paper

• Thromboembolic events in patients who received adjuvant chemotherapy for gastric cancer: a single-center retrospective study

  2023cites this paper
• Prognostic impact of D2-plus lymphadenectomy and optimal extent of lymphadenectomy in advanced gastric antral carcinoma: Propensity score matching analysis

  2020cites this paper
• Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial

  2020cites this paper
• Hypoalbuminemia for the prediction of venous thromboembolism and treatment of direct oral anticoagulants in metastatic gastric cancer patients

  2019cites this paper
• Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial.

  2018cites this paper
• Venous Thromboembolism in Asian Patients with Pancreatic Cancer Following Palliative Chemotherapy: Low Incidence but a Negative Prognosticator for Those with Early Onset

  2018cites this paper
• Bidirectional risk between venous thromboembolism and cancer in East Asian patients: synthesis of evidence from recent population-based epidemiological studies

  2017cites this paper